Introduction: The purposes of this study are to identify a patient cohort that would benefit from the use of mechanical circulatory support (MCS) in the presence of the Eurotransplant high-urgency (HU) program. Methods: Sixty-five patients (heart transplantation (HTx) group, 77%) underwent heart transplantation and 17 patients (D group, 20%) died while on the HU waiting list. These 82 patients were included in this retrospective study. Results: The mean waiting time on HU list was 18.3 ± 17.7 days in HTx group and 12.5 ± 9.4 days in D group (p = 0.075). The average weekly allocation rate from the active HU list was 27.7%, and the mean weekly waiting-list mortality was 12.1%. The use of intra-aortic balloon pumping (p = 0.005), mechanical ventilation (p = 0.007), higher dose of dobutamine (0.005), lower serum level of sodium (p = 0.046), and higher serum level of C reactive protein (CRP) (0.040) at the registration of HU listing were associated with waiting-time mortality, and the serum creatinine level more than 1.5 mg/dl (p = 0.007, odds ratio; 14.5, 95% CI; 2.1-102.0) and the serum CRP level more than 10 mg/l (p = 0.026, odds ratio; 6.3, 95%CI; 1.2-31.4) were identified as significant predictors. Conclusion: It would be appropriate that a patient who would not be able to tolerate one or two weeks waiting time to be considered as a candidate for MCS implantation in the presence of the HU program. The patient selection criteria for MCS implantation should include not only hemodynamic parameters, but also the aspect of a beginning multi-organ failure. © 2008.
Kamiya, H., Koch, A., Sack, F. U., Akhyari, P., Remppis, A., Dengler, T. J., … Lichtenberg, A. (2008). Who needs “bridge” to transplantation in the presence of the Eurotransplant high-urgency heart transplantation program? European Journal of Cardio-Thoracic Surgery, 34(6), 1129–1133. https://doi.org/10.1016/j.ejcts.2008.05.059